StackTerminal.Health

BETA

L-Carnitine / Acetyl-L-Carnitine (ALCAR)

L-Carnitine is a fatty acid transporter essential for mitochondrial energy production; its acetylated form ALCAR additionally crosses the blood-brain barrier, acting as an acetylcholine precursor with evidence supporting cognitive function in aging & cardiovascular-metabolic risk reduction.

cognitivemetaboliclongevitycardiovascularmitochondrial

Evidence last reviewed: 04 Apr 2026

Buy← Back
Evidence
3 records
3 recordsBest grade:Moderate
Biomarkers
Blood PressureHDL CholesterolTriglyceridesBlood GlucoseCognitive Function

Moderate evidence supports ALCAR's role in enhancing cognitive function and reducing depressive symptoms, particularly in older adults. Additionally, L-Carnitine has shown promise in improving metabolic syndrome markers. However, more research is needed to fully understand its long-term effects.

Depressive symptoms
Adults with depressive disorders, including older adults · systematic review and meta-analysis of RCTs
Moderate

Systematic review & meta-analysis found ALCAR significantly reduced depressive symptoms versus placebo or active comparators, with particularly pronounced effects in older adults; effect comparable to antidepressants but with a superior tolerability profile.

Dose: 2000 mgDuration: 8–24 weeks
Citation: Veronese N, Stubbs B, Solmi M, et al. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosom Med. 2018;80(2):154-159.
Cognitive function in mild cognitive impairment & Alzheimer's disease
Adults with mild cognitive impairment or mild Alzheimer's disease · meta-analysis of RCTs
Moderate

Meta-analysis of 21 RCTs (n=1,204 evaluable) found a significant advantage for ALCAR versus placebo on both clinical scales & psychometric tests (ES=0.201, 95% CI 0.107–0.295 for integrated summary effect), with benefits emerging at 3 months & increasing over time at doses of 1.5–3.0 g/day.

Dose: 2000 mgDuration: 3–12 months
Citation: Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol. 2003;18(2):61-71.
Metabolic syndrome biomarkers (waist circumference, blood pressure, lipids, glycemia)
Adults with metabolic syndrome or cardiovascular risk factors · systematic review and meta-analysis of RCTs
Moderate

Meta-analysis of 9 RCTs found L-carnitine (0.75–3 g/day, 8–24 weeks) significantly reduced waist circumference & systolic blood pressure; at doses >1 g/day, fasting blood sugar, triglycerides, & HDL-cholesterol were also significantly improved.

Dose: 1500 mgDuration: 8–24 weeks
Citation: Choi M, Park S, Lee M. L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2020;12(9):2795.
Stacks containing L-Carnitine / Acetyl-L-Carnitine (ALCAR)
Explore all →
mens-healthfertilitytestosterone

Men's Sperm Quality & Testosterone Stack

by@athlete

Male factor infertility accounts for ~50% of cases & is largely driven by oxidative stress, micronutrient deficiency, & suboptimal testosterone. Ashwagandha has RCT evidence for significantly improving sperm concentration, motility, & testosterone. L-carnitine is the most evidence-backed intervention for sperm motility. CoQ10 & selenium reduce seminal oxidative damage, while zinc is essential for spermatogenesis & androgen synthesis.

Ashwagandha
600mg
L-Carnitine / Acetyl-L-Carnitine (ALCAR)
2000mg
Coenzyme Q10
300mg
New
View
Community Insights
Forms & usage▾
How to take it

Take 500–2,000 mg daily, ideally before meals or workouts.

My notes▾
Sign in to keep a private note on L-Carnitine / Acetyl-L-Carnitine (ALCAR).
Sign in